LicianPro

Iambic Therapeutics, Inc. ·

IAM 8-K 2026-10-16

Iambic Therapeutics, Inc. (IAM) 8-K dated 2026-10-16 — accession 0001193125-26-424242.

Iambic Therapeutics, Inc. (IAM) common stock.

Iambic Therapeutics, Inc. filed a 8-K on 2026-10-16. Accession 0001193125-26-424242.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for IAM is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The IAM SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr